Detalles de la búsqueda
1.
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 389(10069): 621-628, 2017 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28017399
2.
Long-term efficacy of a hepatitis E vaccine.
N Engl J Med
; 372(10): 914-22, 2015 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25738667
3.
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.
Lancet
; 385(9984): 2272-9, 2015 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25817373
4.
Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Int J Cancer
; 135(11): 2604-11, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740547
5.
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.
Int J Cancer
; 135(11): 2612-22, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740596
6.
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
Lancet
; 381(9871): 1037-45, 2013 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23352749
7.
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 381(9882): 2024-32, 2013 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23726161
8.
[Value of computer-assisted slide-screening system in ThinPrep cervical cytology].
Zhonghua Bing Li Xue Za Zhi
; 42(9): 609-12, 2013 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-24314247
9.
Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.
Lancet Reg Health West Pac
; 34: 100731, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283969
10.
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial.
Sci Bull (Beijing)
; 68(20): 2448-2455, 2023 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743201
11.
A novel influenza A (H1N1) vaccine in various age groups.
N Engl J Med
; 361(25): 2414-23, 2009 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19846844
12.
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials.
Vaccine
; 40(23): 3216-3227, 2022 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35473663
13.
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Lancet Infect Dis
; 22(12): 1756-1768, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36037823
14.
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
Lancet
; 376(9744): 895-902, 2010 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20728932
15.
Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
Hum Vaccin Immunother
; 17(3): 919-926, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270487
16.
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis.
Expert Rev Vaccines
; 20(1): 1-11, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33434084
17.
TGF-ß1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression.
Asian J Androl
; 23(2): 188-196, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159025
18.
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.
Emerg Microbes Infect
; 10(1): 365-375, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583360
19.
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.
Hum Vaccin Immunother
; 16(7): 1630-1635, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544361
20.
Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.
Hum Vaccin Immunother
; 16(7): 1636-1644, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770068